公司资料
Amicus Therapeutics 股价、新闻与催化剂
- 股票代码:
- FOLD
- 交易所:
- NASDAQ
- 行业:
- Small Molecule Drugs
- 所在地:
- United States
股票表现
14.49 USD (+0.21%)
收盘价
最后更新: 2026年4月24日
—
市值
股价为何变动
目前无法获取 FOLD 的收盘价变动背景。
公司概览
业务概览
Amicus Therapeutics is a rare-disease company focused on Fabry and Pompe disease through commercial therapies and pipeline work.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Amicus sits in specialty biopharma.
商业模式特征
The company combines orphan-drug commercialization with a pipeline that can extend the rare-disease franchise.
生物医药行业定位
Amicus occupies a durable rare-disease niche where commercial execution and label expansion matter more than broad pipeline breadth.
未来催化剂
- Amicus's catalysts are Pombiliti plus Opfolda commercial uptake and continued Galafold execution in Fabry disease. The company is trying to prove that its rare-disease platform can keep compounding beyond a single product cycle.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。